Literature DB >> 17896341

Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas.

Bodour Salhia1, Jeong Hyun Hwang, Christian A Smith, Mitsutoshi Nakada, Fiona Rutka, Marc Symons, James T Rutka.   

Abstract

The generation of contractile force mediated by actin-myosin interactions is essential for cell motility. Myosin activity is promoted by phosphorylation of myosin light chain (MLC). MLC phosphorylation in large part is controlled by kinases that are effectors of Rho family GTPases. Accordingly, in this study we examined the effects of ROCK and Rac1 inhibition on MLC phosphorylation in astrocytoma cells. We found that low concentrations of the ROCK inhibitor Y27632 increased the phosphorylation state of the Triton X-100 soluble fraction of MLC, whereas higher concentrations of Y27632 decreased soluble phospho-MLC. These effects of Y27632 were dependent on Rac1. The soluble form of phospho-MLC comprises about 10% of total phospho-MLC in control cells. Interestingly, ROCK inhibition led to a decrease in the phosphorylation state of total MLC, whereas Rac1 inhibition had little effect. Thus, the soluble form of MLC is differentially regulated by ROCK and Rac1 compared with MLC examined in a total cell extract. We also observed that astrocytoma migration is stimulated by low concentrations of the myosin II inhibitor blebbistatin. However, higher concentrations of blebbistatin inhibit migration leading us to believe that migration has a biphasic dependence on myosin II activity. Taken together, our data show that modulation of myosin II activity is important in determining optimal astrocytoma migration. In addition, these findings suggest that there are at least two populations of MLC that are differentially regulated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17896341     DOI: 10.1002/cm.20240

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  20 in total

1.  A genetic strategy for the dynamic and graded control of cell mechanics, motility, and matrix remodeling.

Authors:  Joanna L MacKay; Albert J Keung; Sanjay Kumar
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

2.  Drak/STK17A Drives Neoplastic Glial Proliferation through Modulation of MRLC Signaling.

Authors:  Alexander S Chen; Joanna Wardwell-Ozgo; Nilang N Shah; Deidre Wright; Christina L Appin; Krishanthan Vigneswaran; Daniel J Brat; Harley I Kornblum; Renee D Read
Journal:  Cancer Res       Date:  2018-12-10       Impact factor: 12.701

3.  Modeling the Axon as an Active Partner with the Growth Cone in Axonal Elongation.

Authors:  Rijk de Rooij; Ellen Kuhl; Kyle E Miller
Journal:  Biophys J       Date:  2018-10-03       Impact factor: 4.033

4.  Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner.

Authors:  Thomas J Turbyville; Demirkan B Gürsel; Robert G Tuskan; Jessica C Walrath; Claudia A Lipschultz; Stephen J Lockett; David F Wiemer; John A Beutler; Karlyne M Reilly
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

5.  PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway.

Authors:  Juhi Singh; Kedarlal Sharma; Prakash P Pillai
Journal:  Cytotechnology       Date:  2017-11-15       Impact factor: 2.058

6.  Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.

Authors:  Paula A Agudelo-Garcia; Jessica K De Jesus; Shante P Williams; Michal O Nowicki; Ennio Antonio Chiocca; Sandya Liyanarachchi; Pui-Kai Li; John J Lannutti; Jed K Johnson; Sean E Lawler; Mariano S Viapiano
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

7.  Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

Authors:  Charles C Chu; Rosa Catera; Katerina Hatzi; Xiao-Jie Yan; Lu Zhang; Xiao Bo Wang; Henry M Fales; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

8.  The Guanine Nucleotide Exchange Factor SWAP-70 Modulates the Migration and Invasiveness of Human Malignant Glioma Cells.

Authors:  Ho Jun Seol; Christian A Smith; Bodour Salhia; James T Rutka
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

Review 9.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

10.  Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology.

Authors:  Shamik Sen; Meimei Dong; Sanjay Kumar
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.